Share
University Hospital Bristol has presented groundbreaking results at the British Radiation Safety Society (BRSS) conference, showcasing the use of TrueInvivo’s® DOSEmapper™ technology in gamma knife radiosurgery. The innovative micro silica bead TLD system provided precise dose measurements, ensuring accurate delivery and improved patient safety in stereotactic radiosurgery.
This marks a significant advancement in dosimetry, highlighting the potential of DOSEmapper™ to enhance radiation safety and accuracy in complex treatments.
Related Posts
Graduate secures vital government backing for innovative cancer treatment, targeting global markets with Sirius Programme.
TRUEinvivo's 2018 achievements include prototype development, patent filings, fundraising, multiple awards, and market expansion, setting the stage for a busy 2019.
TRUEinvivo® receives CE Mark for DOSEmapper Reader, automating radiotherapy dose measurement for enhanced accuracy.
George Sutherland appointed TRUEinvivo Ltd.'s first Chairman, bringing extensive experience in medical devices and corporate finance.
